CTOs on the Move

Georgia Assoc. for Primary Health Care

www.primaryhealthcare.org

 
Georgia Assoc. for Primary Health Care is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Health Research

Health Research is a Rensselaer, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Simulation and Training Environment Laboratory

Simulation and Training Environment Laboratory is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corona-Temecula Orthopaedic Associates

Corona-Temecula Orthopaedic Associates is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cortland Acres Nursing Home

The Cortland Acres community offers a variety of housing choices to meet the needs of active older adults.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.